PMGC 홀딩스(ELAB)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $4.78 (+1.27%), 시가총액 $9.26M, 52주 범위 $0.71 ~ $14.00.
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.
PMGC 홀딩스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
PMGC 홀딩스의 현재 주가는 $4.78 (+1.27%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
PMGC 홀딩스의 시가총액은 약 $9.26M입니다.
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products.